979
Views
12
CrossRef citations to date
0
Altmetric
Original Article

LncRNA NR2F2-AS1 positively regulates CDK4 to promote cancer cell proliferation in prostate carcinoma

, , , &
Pages 1073-1079 | Received 23 Aug 2019, Accepted 17 Sep 2019, Published online: 28 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Xiao-Ru Liang, Yan-Fei Liu, Feng Chen, Zhi-Xia Zhou, Li-Jie Zhang & Zhi-Juan Lin. (2023) Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management. Cancer Management and Research 15, pages 547-561.
Read now
Yujia Xi, Rui Wen, Ran Zhang, Qirui Dong, Sijia Hou & Shengxiao Zhang. (2023) Genetic evidence supporting a causal role of Janus kinase 2 in prostate cancer: a Mendelian randomization study. The Aging Male 26:1.
Read now

Articles from other publishers (9)

Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, Mohammad Hossein Gholami, Kiavash Hushmandi, Mehrdad Hashemi, Azuma Kalu, Ali Zarrabi, Noushin Nabavi, Navid Rabiee, Esmaeel Sharifi, Hassan Karimi-Maleh, Milad Ashrafizadeh, Alan Prem Kumar & Yuzhuo Wang. (2022) Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Jia Ye, Hui He, Sen Chen, Yijun Ren, Weichun Guo & Zhihui Jin. (2022) Long non-coding RNA NR2F2-AS1 regulates human osteosarcoma growth and metastasis through miR-425-5p-mediated HMGB2. International Journal of Clinical Oncology 27:12, pages 1891-1903.
Crossref
Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Peixin Dong, Nikolaus Gassler, Mohammad Taheri, Aria Baniahmad & Nader Akbari Dilmaghani. (2022) A review on the role of cyclin dependent kinases in cancers. Cancer Cell International 22:1.
Crossref
Wen-Jing Zeng, Lei Zhang, Hui Cao, Dongjie Li, Hao Zhang, Zhiwei Xia & Renjun Peng. (2022) A novel inflammation-related lncRNAs prognostic signature identifies LINC00346 in promoting proliferation, migration, and immune infiltration of glioma. Frontiers in Immunology 13.
Crossref
Shadi Ghorbanzadeh, Navid Poor-Ghassem, Masoomeh Afsa, Mohsen Nikbakht & Kianoosh Malekzadeh. (2022) Long non-coding RNA NR2F2-AS1: its expanding oncogenic roles in tumor progression. Human Cell 35:5, pages 1355-1363.
Crossref
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, Sholeh Etehad Asnaf, Afshin Taheriazam, Mehrdad Hashemi, Milad Ashrafizadeh, Ali Zarrabi, Navid Rabiee, Kiavash Hushmandi, Sepideh Mirzaei & Gautam Sethi. (2022) Non-coding RNAs and macrophage interaction in tumor progression. Critical Reviews in Oncology/Hematology 173, pages 103680.
Crossref
Soudeh Ghafouri-Fard, Hamed Shoorei, Farhad Tondro Anamag & Mohammad Taheri. (2020) The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells. Frontiers in Oncology 10.
Crossref
Xi Li, Sihui Yu, Rui Yang, Qi Wang, Xiangnan Liu, Mingjun Ma, Yanli Li & Sufang Wu. (2020) Identification of lncRNA-associated ceRNA network in high-grade serous ovarian cancer metastasis. Epigenomics 12:14, pages 1175-1191.
Crossref
Dan Liu, Kejin Huang, Tiaojiao Wang, Xufeng Zhang, Wentao Liu, Xiaolong Yue & Jin Wu. (2020) NR2F2-AS1 accelerates cell proliferation through regulating miR-4429/MBD1 axis in cervical cancer. Bioscience Reports 40:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.